KTTAW • NASDAQ
Pasithea Therapeutics Corp.
$0.02
Stock Details
| Market Cap | 148,061 |
|---|---|
| Day Change | 0.0076 (61.79%) |
| Volume | 2,000 |
| Avg Volume | 25,405.443 |
| Price Range | 0.0122-0.0199 |
Overview
| Country | US |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | NASDAQ |
Company Profile
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.
Financial Overview
| 52 Week High | 0.048501 |
|---|---|
| 52 Week High Date | 2025-02-05 |
| 52 Week Low | 0.0121 |
| 52 Week Low Date | 2025-10-16 |
| 10D Avg Trading Vol | 0.01928 |
| YTD Price Return Daily | -64.4509 |
| MTD Price Return Daily | -27.2319 |